If you need more lookups,
subscriptions start at $34 USD/month.
Cate Tucknott Location
United Kingdom
Cate Tucknott Work
Senior Vice President @ (September 2026 - Present)
Executive Director, Head of European Clinical Operations and Data Analytics @ (March 2022 - July 2025)
Senior Director, Head of European Clinical Operations @ (September 2017 - February 2022)
Director, Global Study Management @ (October 2010 - April 2017)
Senior Manager @ (October 2004 - September 2010)
Senior Manager, Clinical Research @ (March 2001 - August 2004)
Clinical Associate @ (April 1999 - February 2001)
Cate Tucknott Education
University of Oxford
BA (Biochemistry)
1992-1996
University of Southampton
MSc (Biochemical Pharmacology)
Cate Tucknott Skills
Analytical Skills
Biopharmaceuticals
Biotechnology
Business Strategy
Cardiovascular Disease
Change Management
Clinical Development
Clinical Operations
Clinical Trials
Coaching
Cross-functional Team Leadership
Decision-Making
Drug Development
Employee Engagement
GCP
Gene Therapy
Interpersonal Skills
Leadership
Leadership Development
Life Sciences
Management
Neuroscience
Oncology
Organizational Design
Pharmaceutical Industry
Process Improvement Projects
Program Management
Project Management
Rare Diseases
Resource Management
Senior Stakeholder Management
Stakeholder Engagement
Strategic Partnerships
Strategic Planning
Strategic Thinking
Talent Management
Team Building
Team Leadership
Teamwork
Vendor Partnerships
Clinical Research
Research
Cate Tucknott Summary
Cate Tucknott, based in United Kingdom, is currently a Senior Vice President at CellCentric. Cate Tucknott brings experience from previous roles at BioMarin Pharmaceutical Inc. and Amgen. Cate Tucknott holds a 1992 - 1996 BA in Biochemistry @ University of Oxford. With a robust skill set that includes Analytical Skills, Biopharmaceuticals, Biotechnology, Business Strategy, Cardiovascular Disease and more. Cate Tucknott has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Cate Tucknott?
Find contact details for 700 million professionals.